| Professional Services Industry | Industrials Sector | Douglas Ward CEO | XFRA Exchange | AU0000157091 ISIN |
| AU Country | - Employees | - Last Dividend | 6 Sep 2024 Last Split | - IPO Date |
Lumos Diagnostics Holdings Limited is a pioneering contract research and development firm with a sharp focus on the creation, manufacturing, and commercialization of rapid point-of-care (POC) diagnostic products. These products are essential for the diagnosis and management of infectious diseases, with operations spanning the United States and Australia. Founded in 2004 and headquartered in Melbourne, Australia, Lumos Diagnostics aims to enhance global healthcare by providing quick and reliable diagnostic solutions.
FebriDx stands as a pivotal POC diagnostic test designed for the swift detection and differentiation of viral and bacterial respiratory infections. This innovative product aids healthcare professionals in making informed decisions concerning treatment strategies, facilitating appropriate antibiotic use and reducing the spread of infections.
ViraDx is a comprehensive three-in-one POC test capable of simultaneously detecting influenza A, influenza B, and COVID-19. This test is particularly valuable for its ability to differentiate among these prevalent respiratory viruses, ensuring timely and accurate medical interventions during flu seasons and pandemic outbreaks.
CoviDx is a specialized rapid antigen test for COVID-19, developed to provide quick results concerning COVID-19 infection status. By offering results in a matter of minutes, CoviDx plays a crucial role in the fast tracking of testing and isolation procedures, thus helping to control the spread of the virus effectively.
Lumos Diagnostics also offers a range of reader devices, including desktop, disposable, and the unique Lumos Leelu readers. These devices are designed to work in tandem with the company's diagnostic tests, enhancing the precision, reliability, and user-friendliness of the test results. These readers are integral to the ecosystem of Lumos Diagnostics’ solutions, providing healthcare professionals with advanced tools to interpret test outcomes accurately.